BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984
14 results:

  • 1. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
    Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
    World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. LncRNA RP3-326I13.1 promotes cisplatin resistance in lung adenocarcinoma by binding to hsp90b and upregulating MMP13.
    Zhou H; Huang X; Shi W; Xu S; Chen J; Huang K; Wang Y
    Cell Cycle; 2022 Jul; 21(13):1391-1405. PubMed ID: 35298351
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Extracellular Vesicle and Particle Biomarkers Define Multiple Human cancers.
    Hoshino A; Kim HS; Bojmar L; Gyan KE; Cioffi M; Hernandez J; Zambirinis CP; Rodrigues G; Molina H; Heissel S; Mark MT; Steiner L; Benito-Martin A; Lucotti S; Di Giannatale A; Offer K; Nakajima M; Williams C; Nogués L; Pelissier Vatter FA; Hashimoto A; Davies AE; Freitas D; Kenific CM; Ararso Y; Buehring W; Lauritzen P; Ogitani Y; Sugiura K; Takahashi N; Alečković M; Bailey KA; Jolissant JS; Wang H; Harris A; Schaeffer LM; García-Santos G; Posner Z; Balachandran VP; Khakoo Y; Raju GP; Scherz A; Sagi I; Scherz-Shouval R; Yarden Y; Oren M; Malladi M; Petriccione M; De Braganca KC; Donzelli M; Fischer C; Vitolano S; Wright GP; Ganshaw L; Marrano M; Ahmed A; DeStefano J; Danzer E; Roehrl MHA; Lacayo NJ; Vincent TC; Weiser MR; Brady MS; Meyers PA; Wexler LH; Ambati SR; Chou AJ; Slotkin EK; Modak S; Roberts SS; Basu EM; Diolaiti D; Krantz BA; Cardoso F; Simpson AL; Berger M; Rudin CM; Simeone DM; Jain M; Ghajar CM; Batra SK; Stanger BZ; Bui J; Brown KA; Rajasekhar VK; Healey JH; de Sousa M; Kramer K; Sheth S; Baisch J; Pascual V; Heaton TE; La Quaglia MP; Pisapia DJ; Schwartz R; Zhang H; Liu Y; Shukla A; Blavier L; DeClerck YA; LaBarge M; Bissell MJ; Caffrey TC; Grandgenett PM; Hollingsworth MA; Bromberg J; Costa-Silva B; Peinado H; Kang Y; Garcia BA; O'Reilly EM; Kelsen D; Trippett TM; Jones DR; Matei IR; Jarnagin WR; Lyden D
    Cell; 2020 Aug; 182(4):1044-1061.e18. PubMed ID: 32795414
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Landscape of transcriptome variations uncovering known and novel driver events in colorectal carcinoma.
    Pira G; Uva P; Scanu AM; Rocca PC; Murgia L; Uleri E; Piu C; Porcu A; Carru C; Manca A; Persico I; Muroni MR; Sanges F; Serra C; Dolei A; Angius A; De Miglio MR
    Sci Rep; 2020 Jan; 10(1):432. PubMed ID: 31949199
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. USP22-dependent hsp90ab1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer.
    Kosinsky RL; Helms M; Zerche M; Wohn L; Dyas A; Prokakis E; Kazerouni ZB; Bedi U; Wegwitz F; Johnsen SA
    Cell Death Dis; 2019 Dec; 10(12):911. PubMed ID: 31801945
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of Two Intensive Bowel Cleansing Regimens in Patients With Previous Poor Bowel Preparation: A Randomized Controlled Study.
    Gimeno-García AZ; Hernandez G; Aldea A; Nicolás-Pérez D; Jiménez A; Carrillo M; Felipe V; Alarcón-Fernández O; Hernandez-Guerra M; Romero R; Alonso I; Gonzalez Y; Adrian Z; Moreno M; Ramos L; Quintero E
    Am J Gastroenterol; 2017 Jun; 112(6):951-958. PubMed ID: 28291237
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel variant on chromosome 6p21.1 is associated with the risk of developing colorectal cancer: a two-stage case-control study in Han Chinese.
    Xu C; Zhou D; Pan F; Liu Y; Zhang D; Lin A; Miao X; Ni Y; Lv D; Zhang S; Li X; Zhu Y; Lai M
    BMC Cancer; 2016 Oct; 16(1):807. PubMed ID: 27756247
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass.
    Valcz G; Galamb O; Krenács T; Spisák S; Kalmár A; Patai ÁV; Wichmann B; Dede K; Tulassay Z; Molnár B
    Mod Pathol; 2016 Aug; 29(8):928-38. PubMed ID: 27150162
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proteomic profiling of human colon cancer cells treated with the histone deacetylase inhibitor belinostat.
    Beck HC; Petersen J; Nielsen SJ; Morsczeck C; Jensen PB; Sehested M; Grauslund M
    Electrophoresis; 2010 Aug; 31(16):2714-21. PubMed ID: 20717991
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The database dbEST correctly predicts gene expression in colon cancer patients.
    Radeva M; Hofmann T; Altenberg B; Mothes H; Richter KK; Pool-Zobel B; Greulich KO
    Curr Pharm Biotechnol; 2008 Dec; 9(6):510-5. PubMed ID: 19075689
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A single nucleotide substitution (-107C-->G) in the hMLH1 promoter found in colorectal cancer population reduces transcriptional activity.
    Zhong X; Arita M; Yamada K; Sugiyama H; Tan K; Kanazawa S; Koike J; Teramoto T; Hemmi H
    Biochem Genet; 2007 Oct; 45(9-10):671-81. PubMed ID: 17690979
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets.
    Andersen CL; Jensen JL; Ørntoft TF
    Cancer Res; 2004 Aug; 64(15):5245-50. PubMed ID: 15289330
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature.
    Greenstein AJ; Balasubramanian S; Harpaz N; Rizwan M; Sachar DB
    Am J Gastroenterol; 1997 Apr; 92(4):682-5. PubMed ID: 9128324
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.